
You can purchase shares of HELIX BIOPHARMA CORP by Helix Biopharma Corp. (OTCPK:HBPCF) through any online brokerage.
There are no as such competitors for HELIX BIOPHARMA CORP by Helix Biopharma Corp..
There is no analysis for HELIX BIOPHARMA CORP by Helix Biopharma Corp. to provide a consensus price target.
The stock price for HELIX BIOPHARMA CORP by Helix Biopharma Corp. (OTCPK: HBPCF) is $0.77 last updated September 28, 2026 at 2:44 PM EDT.
There are no upcoming dividends for HELIX BIOPHARMA CORP by Helix Biopharma Corp..
HELIX BIOPHARMA CORP by Helix Biopharma Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for HELIX BIOPHARMA CORP by Helix Biopharma Corp..
HELIX BIOPHARMA CORP by Helix Biopharma Corp. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Helix BioPharma Corp is a clinical-stage oncology company focused on developing therapies for underserved patient populations with difficult-to-treat cancers. The company's pipeline is led by L-DOS47, a clinical-stage antibody-enzyme conjugate being...